Changes in the Prescription of Glucose‐Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study

Changes in the Prescription of Glucose‐Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study

Background Evidence accumulated that some glucose‐lowering medications protect against cardiovascular events (CVEs) in patients with type 2 diabetes mellitus (T2DM) and established cardiovascular disease. The present study evaluated if and how glucose‐lowering medication prescription pattern changes...

Full description

Bibliographic Details
Main Authors: Gian Paolo Fadini, Vera Frison, Natalino Simioni, Annunziata Lapolla, Adriano Gatti, Antonio Carlo Bossi, Andrea Del Buono, Paolo Fornengo, Lucia Gottardo, Mario Laudato, Gianluca Perseghin, Enzo Bonora, Angelo Avogaro
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
appropriateness
diabetes mellitus
pharmacology
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.012244

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.012244

Similar Items